Nilotinib - Novartis Pharmaceuticals Corporation
At a glance
- Drug Originator Novartis Pharmaceuticals Corporation
- Drug Class Anilides; Aniline compounds; Antineoplastics; Benzamides; Fluorinated hydrocarbons; Imidazoles; Ketones; Pyridines; Pyrimidines; Small molecules; Toluenes
- Mechanism of Action Bcr-Abl tyrosine kinase inhibitors; Platelet-derived growth factor alpha receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto-oncogene protein c-kit inhibitors
- USA Patent Applicants NOVARTIS
- USA Patents 11
- NDAs 1
- International Patents 230
- Patent Applications 4,662
Disclaimer